NEW YORK (GenomeWeb) – Norwegian molecular diagnostics firm Genetic Analysis has tapped the Synlab Group and its subsidiary LaborDr. Bayer to offer its GA-map Dysbiosis Test to German laboratories and hospitals.

Genetic Analysis CEO Kari Stenersen in a statement called the deal a "commercial breakthrough" for the Oslo-based company, which achieved a CE-IVD mark for GA-map Dysbiosis last year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.